Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Latest From ADMETRx Inc.

The Buzz around Exploratory INDs

The impact of FDA's Final Guidance on the use of Exploratory IND Studies could be profound for firms ranging from start-ups anticipating their first human drug tests to Big Pharmas with thousands of leads to manage and prioritize. Some service organizations may also benefit from the new regs, which may prompt an early clinical assessment of increasing numbers of compounds.
BioPharmaceutical Clinical Trials


ADMETRx is building new and improved ADME tools. The technology, a mix of wet lab analysis and computer modeling, attempts to move beyond the go/no go decisions typical of ADME.Instead the company offers clients a ranking of a drugs being tested based on the individual properties being tested.
BioPharmaceutical Research and Development Strategies

Start-Up Previews (2/06)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Exploratory INDs, features profiles of Accium Biosciences, ADMETRx and Vitalea Science. Plus these Start-Ups Across Health Care: Cappella, Cara Therapeutics, Incisive Surgical, Ocera Therapeutics and Ulthera.
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • ADMETRx Inc.
  • Senior Management
  • Contact Info
  • ADMETRx Inc.
    Phone: (269) 372-3272
    4717 Campus Drive
    Ste. 600
    Kalamazoo, MI 49008